🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"Fauna Bio is built on an idea that made veteran VCs do a double take," writes Nick Paul Taylor, highlighting Fauna as one of FierceBiotech's fifteen best biotechs of 2024. Read about their different approach to biomedical drug discovery, and how co-founders Ashley Zehnder, Katie

California Life Sciences (CLS) is excited to celebrate innovation & excellence in the life sciences at the #PantheonAwards! Hear from past winner Fauna Bio who were honored with the 2022 #EmergingInnovationAward! 🎟️ Purchase tickets: bit.ly/3ThW9zI 📅 11/7/24 📍Location: San Francisco

We’re humbled for our work to be featured in Nature Medicine. Thanks for speaking with our CEO Ashley Zehnder and we’re excited to keep everyone updated on our progress! More soon. #hiberation #biology #obesity nature.com/articles/s4159…

Excited to be speaking alongside Ashley Zehnder September 26th- Women in Bio (WIB) panel- Transforming Drug Discovery- How AI/ML and Women Leaders are Changing the Game. Register:  community.womeninbio.org/event/sanfran9…

The NASA NIAC symposium is free to live stream. Current projects from proof of concept to launch are being presented and discussed! Be sure to check out our Fauna Bio project presented by Dr. Sprenger on Sept. 11th at 11:30 Pacific time. vimeo.com/showcase/10973…

Our CEO Ashley Zehnder will be speaking at LSX Leaders in Boston today at 11 am ET. Hope to see you all there! Sharing more info: informaconnect.com/lsx-world-cong…

.Neil deGrasse Tyson, Chuck Nice, and Gary O’Reilly team up with Ryan Sprenger, Senior Research Scientist at Fauna Bio, to explore a question straight out of science fiction: can humans #hibernate in space like animals do on Earth? StarTalk 🌎🪐 Watch here: youtu.be/Ph5cr3KSCUg?si…

Our CEO Ashley Zehnder will be speaking at the #BIO Investor Forum today at 1 pm PT. Check out the agenda: bif.bio.org/event-overview

Ashley Zehnder Fauna Bio discusses the insights that can be gleaned from the genetics of hibernating animals, the human health conditions that might be addressed with the approach, and the company’s deal with Eli Lilly to discover new obesity drugs. thebioreport.podbean.com/e/going-to-ext…

Our CEO Ashley Zehnder spoke with C&EN (Chemical & Engineering News) reporter Rowan Walrath 😷 about founder-led #biotechs 🔥🔥🔥 cen.acs.org/business/start…

📣 Speaker Announcement! We’re excited to announce that Ashley Zehnder, Co-Founder & CEO at Fauna Bio will be speaking at Biotech Showcase 2025! Find out more about what is in store at Biotech Showcase >> spr.ly/6010Qj5vq #BiotechShowcase #Biotech #Financing

We’re excited to select Faun1083 as our first development candidate. Discovered through our proprietary Convergence™ drug discovery platform, Faun1083 is a potential first-in-class therapeutic targeting heart failure with preserved ejection fraction. 🧬 businesswire.com/news/home/2025…

Our CEO & Co-Founder Ashley Zehnder will be speaking at the Stanford Medicine SIC Venture Studio next Tuesday Jan 14, 11.30 am PT during #JPM25 Healthcare Conference. 🧬🧬 Register to attend: 👇👇 lu.ma/x7iuffoo

Our CEO & Co-Founder Ashley Zehnder on the SIC Ventures and Stanford Medicine event at #JPM25. Great discussion with female execs discussing raising funding for their biotech. 🧬🧬

Our CEO Ashley Zehnder will be at #InvestivalShowcase in Miami, March 10-11. LSX Leaders More info here: informaconnect.com/investival-sho…

Our CEO Ashley Zehnder will be speaking at SynBioBeta on May 7 at 4.30 pm. More info here: synbiobeta.com